对具有高复发风险的绝经后乳腺癌患者进行抗雌激素治疗：72个月的生命表分析及类固醇激素受体状态 - Suppr

Suppr

超能文献

Anti-estrogen treatment of postmenopausal breast cancer patients with high risk of recurrence: 72 months of life-table analysis and steroid hormone receptor status.

作者信息

Rose C, Mouridsen H T, Thorpe S M, Andersen J, Blichert-Toft M, Andersen K W

出版信息

World J Surg. 1985 Oct;9(5):765-74. doi: 10.1007/BF01655192.

DOI:10.1007/BF01655192

PMID:4060747

Abstract

摘要

相似文献

Anti-estrogen treatment of postmenopausal breast cancer patients with high risk of recurrence: 72 months of life-table analysis and steroid hormone receptor status.

World J Surg. 1985 Oct;9(5):765-74. doi: 10.1007/BF01655192.

Adjuvant therapy with tamoxifen in operable breast cancer. 10 year results of the Naples (GUN) study.

Lancet. 1988 Nov 12;2(8620):1095-9.

Antiestrogen treatment of postmenopausal women with primary high risk breast cancer.

Breast Cancer Res Treat. 1983;3(1):77-84. doi: 10.1007/BF01806237.

Endocrine versus endocrine plus five-drug chemotherapy in postmenopausal women with stage II estrogen receptor-positive breast cancer.

Cancer. 1989 Nov 1;64(9):1819-23. doi: 10.1002/1097-0142(19891101)64:9<1819::aid-cncr2820640910>3.0.co;2-n.

[Adjuvant endocrine treatment of postmenopausal patients with breast cancer with high risk of recurrence. 5. Results from the DBCG (Danish Breast Cancer Cooperative Group) 77C randomized trial].

Ugeskr Laeger. 1991 Aug 12;153(33):2283-7.

Adjuvant systemic therapy in primary breast cancer.

Acta Chir Scand Suppl. 1984;519:43-53.

Beneficial effect of adjuvant tamoxifen therapy in primary breast cancer patients with high oestrogen receptor values.

Lancet. 1985 Jan 5;1(8419):16-9. doi: 10.1016/s0140-6736(85)90966-3.

Evaluation of estrogen dependency of human breast cancers. II. Clinical evaluation of tamoxifen in advanced primary and recurrent breast cancer.

Hiroshima J Med Sci. 1984 Jun;33(2):163-6.

The relationship between hormone receptor content and the effect of adjuvant tamoxifen in operable breast cancer.

J Clin Oncol. 1989 Oct;7(10):1474-84. doi: 10.1200/JCO.1989.7.10.1474.

[For postmenopausal women with hormone-dependent tumors. Aromatase inhibitors are the new gold standard].

MMW Fortschr Med. 2006 Mar 23;148(12):10.

引用本文的文献

A pilot study of estrogen receptor (ER) expression in pancreatic ductal adenocarcinoma (PDAC).

Transl Gastroenterol Hepatol. 2021 Jan 5;6:9. doi: 10.21037/tgh.2020.02.16. eCollection 2021.

A prospective analysis of immunohistochemically determined hormone receptors and nuclear features as predictors of early recurrence in primary breast cancer.

Breast Cancer Res Treat. 1995;36(1):11-21. doi: 10.1007/BF00690180.

The predictive value of steroid hormone receptor analysis in breast, endometrial and ovarian cancer.

Med Oncol Tumor Pharmacother. 1986;3(3-4):197-210. doi: 10.1007/BF02934996.

Adjuvant systemic therapy: state of the art, 1989.

Breast Cancer Res Treat. 1989 Oct;14(1):3-22. doi: 10.1007/BF01805971.

本文引用的文献

Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years.

Br J Cancer. 1957 Sep;11(3):359-77. doi: 10.1038/bjc.1957.43.

Estrogen receptor quantitation and staging as complementary prognostic indicators in breast cancer: a study of 583 patients.

Int J Cancer. 1981 Dec;28(6):677-83. doi: 10.1002/ijc.2910280604.

Oestrogen-receptor status and sites of metastasis in breast cancer.

Br J Cancer. 1981 Sep;44(3):456-9. doi: 10.1038/bjc.1981.205.

Organisation of the Danish adjuvant trials in breast cancer.

Dan Med Bull. 1981 Aug;28(3):102-6.

Steroid receptors in adjuvant hormonal therapy for breast cancer.

Can J Surg. 1981 May;24(3):290-3.

Rationale for the use of alternating non-cross-resistant chemotherapy.

Cancer Treat Rep. 1982 Mar;66(3):439-49.

Symposium on the management of early breast cancer (stages I and II). Part II: Clinical experience with treatment methods. 5. Adjuvant endocrine therapy.

Can J Surg. 1981 Jul;24(4):379-84.

Therapeutic effect of tamoxifen related to estrogen receptor level.

Recent Results Cancer Res. 1980;71:134-41. doi: 10.1007/978-3-642-81406-8_19.

Treatment of advanced breast cancer with tamoxifen.

Recent Results Cancer Res. 1984;91:230-42. doi: 10.1007/978-3-642-82188-2_33.

Standardization of steroid receptor assays in human breast cancer--I. Reproducibility of estradiol and progesterone receptor assays.

Eur J Cancer Clin Oncol. 1983 Sep;19(9):1221-9. doi: 10.1016/0277-5379(83)90199-2.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验